2.0
Nov 27, 2019
Current employee, more than 10 years
Los Angeles, CA
Recommend
CEO approval
Business Outlook
Pros
Great people, most laid off or left.
Cons
Nothing to sell and no pipeline. Oncology/Keytruda division has too many reps with no access.